← All organizations
Highest phase reached
Phase 3
First clinical trial
Sep 1, 2008Last known activity
Dec 25, 2025
Timeline
2000s
- Jun 1, 2000
Galmed Pharmaceuticals Ltd— Founded
Drugs by trial phase (8 distinct, 16 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (4 own, 0 via acquisition)
Phase 1 (3 own, 0 via acquisition)
Indications
Recent trials (17)
- NCT07251712Lead sponsorPhase 1Dec 25, 2025
- NCT06502561Lead sponsorPhase 1Oct 31, 2024
- NCT06095986Lead sponsorPhase 2Jun 30, 2024
- NCT05857215Lead sponsorPhase 1Mar 5, 2021
- NCT05874336Lead sponsorPhase 1Jun 17, 2020
- NCT04480827Lead sponsorPhase 1Jan 22, 2020
- NCT04104321Lead sponsorPhase 3Sep 30, 2019
- NCT03774173Lead sponsorPhase 1Dec 8, 2018
- NCT03760848Lead sponsorPhase 1Nov 12, 2018
- NCT02803996Lead sponsorPhase 1May 1, 2016
- NCT02279524Lead sponsorPhase 2/Phase 3Jan 1, 2015
- NCT02325492Lead sponsorPhase 2Oct 1, 2014
- NCT02374437Lead sponsorPhase 1Apr 1, 2014
- NCT02374437Study directorPhase 1Apr 1, 2014
- NCT01362361CollaboratorPhase 2Jun 1, 2011
Details
- Founded
- Tel Aviv, IL Jun 1, 2000
- Last known activity
- Dec 25, 2025